Faderl, S.H., Kantarjian, H.M., Estey, Elihu H. (Eds.)
2008, X, 294 p.
Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
Massive practical value as clinicians are brought up to date on most recent advances in acute leukemia treatment
Authors delineate the development of new therapies
Lays out the current state of knowledge on the subject
Examines new classification systems that have been coming on stream
It is one of the most crucial areas of exploration in medicine today – and here is an important addition to the literature on the subject.
As research into cancers progresses, scientists are becoming ever more aware that better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells.
This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis.
Estey, Faderl and Kantarjian, who all work at the respected Anderson Cancer Center in Houston, Texas, USA, examine in detail advances in the treatment of particular types of acute leukemia.
Their book also covers the management of acute leukemia in general as well as the development of new therapies.